Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:32 PM
Ignite Modification Date:
2025-12-24 @ 4:32 PM
NCT ID:
NCT06780566
Eligibility Criteria:
Inclusion Criteria:
* Adult patients aged 18 years or above
* Intended for admission to hospital with acute respiratory illness (defined as a provisional diagnosis of pneumonia, bronchitis, influenza-like illness, acute exacerbation of chronic obstructive pulmonary disease, asthma or bronchiectasis.)
* Respiratory symptoms present ≤10 days before admission to hospital
* No prior treatment with antibiotics or antivirals in the previous 14 days
Exclusion Criteria:
* Refusal of nasal or pharyngeal swabbing
* Refusal of informed consent
* Previously included in the study and re-presentation within 28 days of hospital discharge
* A prior positive test by antigen test or other PCR test for COVID-19 or influenza before ED presentation
* Exposure to FluMist® or other similar live attenuated influenza vaccines within 1 month (because such exposures may lead to a false positive PCR test result with the nasal swab sample).
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT06780566
Study Brief:
Protocol Section:
NCT06780566